US6547827B2
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
Assignee: Edwards Lifesciences Corp
•
Filing: 2001-04-06
•
Granted: 2003-04-15
•
Expires: 2021-04-06
Abstract
Abstract A method for fixation of biological tissues, and bioprosthetic devices prepared by such method. The method generally comprises the steps of A) fixing the tissue, B) treating the tissue with a mixture of i) a denaturant, ii) a surfactant and iii) a crosslinking agent, C) fabricating or forming the bioprosthesis (e.g., forming the tissue and attaching any non-biological components thereto) and D) subjecting the bioprosthesis to terminal sterilization.
Inventors
- 👤 Alain F. Carpentier
- 👤 Sophie Carpentier
- 👤 Crystal M. Cunanan
- 👤 Lillian Quintero
- 👤 Michael N. Helmus
- 👤 Christine Loshbaugh
- 👤 H. Chris Sarner
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 06:48
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/3683; A61L27/3691; A61L2/00; A61L2/16; A61L2/18; A61L27/3604; A61L27/3641; A61L27/3645; A61L27/3687; A61L33/00; A61L33/06; A61L33/12; A61P; A61P19/00; A61L2103/00; A61L2103/05; A61L2400/00; A61L2400/02; A61L2430/00; A61L2430/40; Y; Y10; Y10S; Y10S623/00; Y10S623/901; Y10S623/915; Y10S623/916; Y10S623/917; Y10S623/92
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
110 words
A method for forming a bioprosthesis including treatment of biological tissue which contains connective tissue protein to reduce the potential for post-implantation calcification and thrombogenicity, said method comprising the steps of: a. contacting the biological tissue with a mixture of a denaturant, a surfactant and a crosslinking agent; b. assembling the bioprosthesis by performing any required shaping of the biological tissue and attaching any non-biological components of the bioprosthesis to the biological tissue; and, c. after completion of steps a and b, as a final step of said method, immersing the bioprosthesis in a liquid terminal sterilization solution and heating said terminal sterilization to a temperature between about 35-50° C.
Claim 2
Independent Claim
110 words
A method for forming a bioprosthesis including treatment of biological tissue which contains connective tissue protein to reduce the potential for post-implantation calcification and thrombogenicity, said method comprising the steps of: a. contacting the biological tissue with a mixture of a denaturant, a surfactant and a crosslinking agent; b. assembling the bioprosthesis by performing any required shaping of the biological tissue and attaching any non-biological components of the bioprosthesis to the biological tissue; and, c. after completion of steps a and b, as a final step of said method, immersing the bioprosthesis in a liquid terminal sterilization solution and heating said terminal sterilization to a temperature between about 35-50° C.
Claim 3
Dependent Claim
40 words
The method of claim 1 wherein step c further comprises maintaining the temperature of said liquid terminal sterilization solution between 35-50° C for a period of time sufficient to ensure the sterility of the bioprosthesis until the time of implantation.
Claim 4
Dependent Claim
32 words
The method of claim 2 wherein step c is carried out in a sealed container and further comprises allowing the bioprosthesis to remain within said sealed container until the time of implantation.
Claim 5
Dependent Claim
26 words
The method of claim 2 wherein said terminal sterilization solution comprises an aqueous solution of 0.2-2.0% by weight glutaraldehyde buffered to a pH of approximately 7.4.
Claim 6
Dependent Claim
38 words
The method of claim 2 wherein said terminal sterilization solution comprises an osmotically balanced salt solution in the absence of other chemical sterilants and wherein said sterilization solution is heated to a temperature of at least 45° C.
Claim 7
Dependent Claim
23 words
The method of claim 2 wherein said terminal sterilization solution comprises osmotically balanced salt solution in combination with at least one chemical sterilant.
Claim 8
Dependent Claim
32 words
The method of claim 2 wherein said terminal sterilization solution comprises at least one component selected from the group consisting of i) a denaturant, ii) a surfactant, and iii) a crosslinking agent.
Claim 9
Dependent Claim
107 words
The method of claim 2 wherein step c comprises: a. dispensing into a container a quantity of said terminal sterilization solution comprising 0.2-2.0% by weight glutaraldehyde buffered to a pH of approximately 7.4; b. immersing the bioprosthesis in said terminal sterilization solution within said container; c. sealing said container; d. heating said container, and the terminal sterilization solution and bioprosthesis contained therein, to a temperature of 35-50° C. for 1-6 days; e. cooling said container, and the terminal sterilization solution and bioprosthesis contained therein, to room temperature; and, f. allowing said container to remain sealed until it is desired to implant the bioprosthesis in a mammalian patient.
Claim 10
Independent Claim
95 words
A method for treatment of biological tissue which contains connective tissue protein to reduce the potential for post-implantation calcification and thrombogenicity, said method comprising the steps of: a. crosslinking the connective tissue protein within the biological tissue with a fixative agent; b. contacting the biological tissue with a mixture of a denaturant, a surfactant and a crosslinking agent; c. after completion of steps a and b, as a final step of said method, immersing the biological tissue in a liquid terminal sterilization solution and heating said terminal sterilization to a temperature between about 35-50° C.
Claim 11
Independent Claim
95 words
A method for treatment of biological tissue which contains connective tissue protein to reduce the potential for post-implantation calcification and thrombogenicity, said method comprising the steps of: a. crosslinking the connective tissue protein within the biological tissue with a fixative agent; b. contacting the biological tissue with a mixture of a denaturant, a surfactant and a crosslinking agent; c. after completion of steps a and b, as a final step of said method, immersing the biological tissue in a liquid terminal sterilization solution and heating said terminal sterilization to a temperature between about 35-50° C.
Claim 12
Dependent Claim
41 words
The method of claim 9 wherein step c further comprises maintaining the temperature of said liquid terminal sterilization solution between 35-50° C. for a period of time sufficient to ensure the sterility of the biological tissue until the time of use.
Claim 13
Dependent Claim
33 words
The method of claim 10 wherein step c is carried out in a sealed container and further comprises allowing the biological tissue to remain within said sealed container until the time of use.
Claim 14
Dependent Claim
26 words
The method of claim 64 wherein said terminal sterilization solution comprises an aqueous solution of 0.2-2.0% by weight glutaraldehyde buffered to a pH of approximately 7.4.
Claim 15
Dependent Claim
38 words
The method of claim 10 wherein said terminal sterilization solution comprises an osmotically balanced salt solution in the absence of other chemical sterilants and wherein said sterilization solution is heated to a temperature of at least 45° C.
Claim 16
Dependent Claim
23 words
The method of claim 10 wherein said terminal sterilization solution comprises osmotically balanced salt solution in combination with at least one chemical sterilant.
Claim 17
Dependent Claim
32 words
The method of claim 10 wherein said terminal sterilization solution comprises at least one component selected from the group consisting of i) a denaturant, ii) a surfactant, and iii) a crosslinking agent.
Claim 18
Dependent Claim
107 words
The method of claim 10 wherein step c comprises: a. dispensing into a container a quantity of said terminal sterilization solution comprising 0.2-2.0% by weight glutaraldehyde buffered to a pH of approximately 7.4; b. immersing the biological tissue in said terminal sterilization solution within said container; c. sealing said container; d. heating said container, and the terminal sterilization solution and biological tissue contained therein, to a temperature of 35-50° C. for 1-6 days; e. cooling said container, and the terminal sterilization solution and biological tissue contained therein, to room temperature; and f. allowing said container to remain sealed until it is desired to use the biological tissue.
References Cited (Backward Citations)
US4120649A
Cited
US4648881A
Cited
EP0103946A2
Cited
WO1984001879A1
Cited
US4885005A
Cited
US5215541A
Cited
US4729139A
Cited
US4786287A
Cited
US4976733A
Cited
US5002566A
Cited
US5437287A
Cited
US5447536A
Cited
WO1996004028A1
Cited
US5931969A
Cited
US5674298A
Cited
US5935168A
Cited
US5911951A
Cited
WO1998046288A1
Cited
US5891196A
Cited
US6008292A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2006-04-14 | 2006-10-14 | 2007-04-15 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2010-04-14 | 2010-10-14 | 2011-04-15 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2014-04-14 | 2014-10-14 | 2015-04-15 | $7700.00 | Window Closed / Lapsed |